间充质干细胞的中医理论归属探讨

被引:9
作者
张爱娟 [1 ]
王汉裕 [2 ]
邝卫红 [3 ]
机构
[1] 青岛市口腔医院
[2] 天津市干细胞再生医学转化企业重点实验室
[3] 广州中医药大学
关键词
间充质干细胞; 先天之精; 后天之精; 本虚标实; 中医病机;
D O I
10.13359/j.cnki.gzxbtcm.2016.02.024
中图分类号
R22 [中医基础理论];
学科分类号
100501 [中医基础理论];
摘要
分析有关间充质干细胞(MSCs)现代医学研究成果并引用中医医籍相关论述,探讨MSCs的中医理论归属问题。认为从中医理论精的先天与后天两大来源,以及精的繁衍生殖、生长发育、生髓化血、濡养脏腑四大功能角度来看,MSCs增殖、分化、生物发育机制等特性与中医学中具有繁衍生殖、生长发育、生髓化血、濡养脏腑四大功能的精有诸多相似相通之处,尤其是先天之精与MSCs直接相关;正常MSCs具有较强的免疫调节能力,其作用类似中医的固本祛邪功效;患者MSCs的功能缺陷和中医的正气虚弱两者之间可能存在某种相关性,且带有某种功能缺陷的MSCs患者缺乏抵抗病邪的能力;患者MSCs的功能缺陷源于正气虚弱及邪之所聚。以上探讨对中医研究MSCs有所启示。
引用
收藏
页码:258 / 261
页数:4
相关论文
共 16 条
[1]
Dexamethasone has variable effects on mesenchymal stromal cells [J].
Wang, Hanyu ;
Pang, Bo ;
Li, Yan ;
Zhu, Delin ;
Pang, Tianxiang ;
Liu, Yongjun .
CYTOTHERAPY, 2012, 14 (04) :423-430
[2]
Stimulation of Liver Regeneration After Hepatectomy in Mice by Injection of Bone Marrow Mesenchymal Stem Cells via the Portal Vein [J].
Kaibori, M. ;
Adachi, Y. ;
Shimo, T. ;
Ishizaki, M. ;
Matsui, K. ;
Tanaka, Y. ;
Ohishi, M. ;
Araki, Y. ;
Okumura, T. ;
Nishizawa, M. ;
Kwon, A. H. .
TRANSPLANTATION PROCEEDINGS, 2012, 44 (04) :1107-1109
[3]
Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients.[J].ZhengZhang;HuLin;MingShi;RuonanXu;JunliangFu;JiyunLv;LimingChen;SaLv;YuanyuanLi;ShuangjieYu;HuaGeng;LeiJin;George K KLau;Fu‐ShengWang.Journal of Gastroenterology and Hepatology.2012,
[4]
Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy [J].
Kemp, Kevin ;
Morse, Ruth ;
Wexler, Sarah ;
Cox, Christine ;
Mallam, Elizabeth ;
Hows, Jill ;
Donaldson, Craig .
ANNALS OF HEMATOLOGY, 2010, 89 (07) :701-713
[5]
Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura [J].
Antonio Perez-Simon, Jose ;
Tabera, Soraya ;
Eugenia Sarasquete, Maria ;
Diez-Campelo, Maria ;
Canchado, Javier ;
Ignacio Sanchez-Abarca, Luis ;
Blanco, Belen ;
Alberca, Ignacio ;
Herrero-Sanchez, Carmen ;
Canizo, Consuelo ;
San Miguel, Jesus F. .
CYTOTHERAPY, 2009, 11 (06) :698-705
[6]
Stem cell therapy for liver disease: Parameters governing the success of using bone marrow mesenchymal stem cells [J].
Kuo, Tom K. ;
Hung, Shun-Pei ;
Chuang, Chiao-Hui ;
Chen, Chien-Tsun ;
Shih, Yu-Ru V. ;
Fang, Szu-Ching Y. ;
Yang, Vincent W. ;
Lee, Oscar K. .
GASTROENTEROLOGY, 2008, 134 (07) :2111-2121
[7]
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement [J].
Dominici, M. ;
Le Blanc, K. ;
Mueller, I. ;
Slaper-Cortenbach, I. ;
Marini, F. C. ;
Krause, D. S. ;
Deans, R. J. ;
Keating, A. ;
Prockop, D. J. ;
Horwitz, E. M. .
CYTOTHERAPY, 2006, 8 (04) :315-317
[8]
T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia [J].
Bacigalupo, A ;
Valle, M ;
Podestà, M ;
Pitto, A ;
Zocchi, E ;
De Flora, A ;
Pozzi, S ;
Luchetti, S ;
Frassoni, F ;
Van Lint, MT ;
Piaggio, G .
EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) :819-827
[9]
Clarification of the nomenclature for MSC: The international society for cellular therapy position statement [J].
Horwitz, EM ;
Le Blanc, K ;
Dominici, M ;
Mueller, I ;
Slaper-Cortenbach, I ;
Marini, FC ;
Deans, RJ ;
Krause, DS ;
Keating, A .
CYTOTHERAPY, 2005, 7 (05) :393-395
[10]
Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model [J].
Silva, GV ;
Litovsky, S ;
Assad, JAR ;
Sousa, ALS ;
Martin, BJ ;
Vela, D ;
Coulter, SC ;
Lin, J ;
Ober, J ;
Vaughn, WK ;
Branco, RVC ;
Oliveira, EM ;
He, RM ;
Geng, YJ ;
Willerson, JT ;
Perin, EC .
CIRCULATION, 2005, 111 (02) :150-156